Cargando…
UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185
Background: Esophageal cancer is the sixth-most common fatal malignant tumor worldwide. Little is known regarding the genetic drivers that influence targeted therapy outcomes in patients with esophageal cancer. Exploring the pathogenesis of this lethal tumor could provide clues for developing approp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375240/ https://www.ncbi.nlm.nih.gov/pubmed/34421347 http://dx.doi.org/10.7150/ijbs.61117 |
_version_ | 1783740283600502784 |
---|---|
author | Zheng, Zhikun Zhang, Bin Yu, Haixin Li, Shoukang Song, Naicheng Jin, Xin Li, Jinsong |
author_facet | Zheng, Zhikun Zhang, Bin Yu, Haixin Li, Shoukang Song, Naicheng Jin, Xin Li, Jinsong |
author_sort | Zheng, Zhikun |
collection | PubMed |
description | Background: Esophageal cancer is the sixth-most common fatal malignant tumor worldwide. Little is known regarding the genetic drivers that influence targeted therapy outcomes in patients with esophageal cancer. Exploring the pathogenesis of this lethal tumor could provide clues for developing appropriate therapeutic drugs. Ubiquitin-protein ligase E3A (UBE3A) reportedly promotes or suppresses various types of malignant tumors. However, the cancer-related role of UBE3A in esophageal cancer remains unclear. Methods: The relationship of UBE3A with the clinicopathological features of pancreatic tumors was bioinformatically investigated in the TCGA dataset. The protein levels of UBE3A and ZNF185 were assessed by Western blot and immunohistochemistry. The role of UBE3A and ZNF185 in esophageal cancer growth was assessed by MTS assays, colony formation assays, and experiments in mouse xenograft models. The interaction between UBE3A and ZNF185 was investigated by co-immunoprecipitation. The relationship between UBE3A, ZNF185, and NOTCH signaling pathway was explored by Western blot and quantitative real-time PCR. Results: We found that UBE3A was upregulated in patients with esophageal cancer and enhanced the cellular progression of esophageal cancer. Moreover, we found that UBE3A degraded ZNF185 in esophageal cancer. Additionally, ZNF185 suppressed the progression of esophageal cancer by inactivating the NOTCH pathway. Conclusions: These data demonstrated that aberrant expression of UBE3A led to enhanced progression of esophageal cancer through the ZNF185/NOTCH signaling axis. Therefore, UBE3A might be an ideal therapeutic candidate for esophageal cancer. |
format | Online Article Text |
id | pubmed-8375240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-83752402021-08-19 UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 Zheng, Zhikun Zhang, Bin Yu, Haixin Li, Shoukang Song, Naicheng Jin, Xin Li, Jinsong Int J Biol Sci Research Paper Background: Esophageal cancer is the sixth-most common fatal malignant tumor worldwide. Little is known regarding the genetic drivers that influence targeted therapy outcomes in patients with esophageal cancer. Exploring the pathogenesis of this lethal tumor could provide clues for developing appropriate therapeutic drugs. Ubiquitin-protein ligase E3A (UBE3A) reportedly promotes or suppresses various types of malignant tumors. However, the cancer-related role of UBE3A in esophageal cancer remains unclear. Methods: The relationship of UBE3A with the clinicopathological features of pancreatic tumors was bioinformatically investigated in the TCGA dataset. The protein levels of UBE3A and ZNF185 were assessed by Western blot and immunohistochemistry. The role of UBE3A and ZNF185 in esophageal cancer growth was assessed by MTS assays, colony formation assays, and experiments in mouse xenograft models. The interaction between UBE3A and ZNF185 was investigated by co-immunoprecipitation. The relationship between UBE3A, ZNF185, and NOTCH signaling pathway was explored by Western blot and quantitative real-time PCR. Results: We found that UBE3A was upregulated in patients with esophageal cancer and enhanced the cellular progression of esophageal cancer. Moreover, we found that UBE3A degraded ZNF185 in esophageal cancer. Additionally, ZNF185 suppressed the progression of esophageal cancer by inactivating the NOTCH pathway. Conclusions: These data demonstrated that aberrant expression of UBE3A led to enhanced progression of esophageal cancer through the ZNF185/NOTCH signaling axis. Therefore, UBE3A might be an ideal therapeutic candidate for esophageal cancer. Ivyspring International Publisher 2021-07-13 /pmc/articles/PMC8375240/ /pubmed/34421347 http://dx.doi.org/10.7150/ijbs.61117 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Zheng, Zhikun Zhang, Bin Yu, Haixin Li, Shoukang Song, Naicheng Jin, Xin Li, Jinsong UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 |
title | UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 |
title_full | UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 |
title_fullStr | UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 |
title_full_unstemmed | UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 |
title_short | UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185 |
title_sort | ube3a activates the notch pathway and promotes esophageal cancer progression by degradation of znf185 |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375240/ https://www.ncbi.nlm.nih.gov/pubmed/34421347 http://dx.doi.org/10.7150/ijbs.61117 |
work_keys_str_mv | AT zhengzhikun ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 AT zhangbin ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 AT yuhaixin ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 AT lishoukang ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 AT songnaicheng ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 AT jinxin ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 AT lijinsong ube3aactivatesthenotchpathwayandpromotesesophagealcancerprogressionbydegradationofznf185 |